REFERENCES
- Jefferson JW, Pradko JF, Muir KT. Bupropion for major depressive
disorder: Pharmacokinetic and formulation considerations. Clin Ther
2005;27:1685-1695.
- Benowitz NL, Zhu AZ, Tyndale RF, Dempsey D. Influence of CYP2B6
genetic variants on plasma and urine concentrations of bupropion and
metabolites at steady state. Pharmacogenet Genom 2013;23:135-141.
- Sridar C, Kenaan C, Hollenberg PF. Inhibition of bupropion metabolism
by selegiline: mechanism-based inactivation of human CYP2B6 and
characterization of glutathione and peptide adducts. Drug Metab Dispos
2012;40:2256-2266.
- Daviss WB, Perel JM, Birmaher B, Rudolph GR, Melhem I, Axelson DA,et al . Steady-state clinical pharmacokinetics of bupropion
extended-release in youths. J Am Acad Child Psy 2006;45:1503-1509.
- Nirogi R, Palacharla RC, Mohammed AR, Manoharan A, Ponnamaneni RK,
Bhyrapuneni G. Evaluation of metabolism dependent inhibition of CYP2B6
mediated bupropion hydroxylation in human liver microsomes by
monoamine oxidase inhibitors and prediction of potential as
perpetrators of drug interaction. Chem-Biol Interact 2015;230:9-20.
- Kirchheiner J, Klein C, Meineke I, Sasse J, Zanger UM, Mürdter TE,et al . Bupropion and 4-OH-bupropion pharmacokinetics in
relation to genetic polymorphisms in CYP2B6. Pharmacogenetics
2003;13:619-626.
- Zanger U, Klein K, Blievernicht T J, Hofmann MH, Schwab M. Polymorphic
CYP2B6: molecular mechanisms and emerging clinical significance.
Pharmacogenomics 2007;8:743-759.
- Hesse LM, Venkatakrishnan K, Court MH, Moltke LL, Duan SX, Shader RI,et al . CYP2B6 mediates the in vitro hydroxylation of bupropion:
potential drug interactions with other antidepressants. Drug Metab
Dispos 2000;28:1176-1183.
- Stäuble CK, Lampert ML, Mikoteit T, Hatzinger M, Hersberger
KE, Schwabedissen HEMZ. Nonresponse to high-dose bupropion for
depression in a patient carrying CYP2B6*6 and CYP2C19*17 variants: a
case report.Pharmacogenomics 2020 ;21(16):1145-1150.
- Tomaz PR, Santos JR, Issa JS, Abe TO, Gaya PV, Krieger JE, et
al . CYP2B6 rs2279343 polymorphism is associated with smoking
cessation success in bupropion therapy. European J Clin Pharmacol
2015;71:1-7.
- Høiseth G, Haslemo T, Uthus LH, Molden E. Effect of CYP2B6*6 on
steady-state serum concentrations of bupropion and hydroxybupropion in
psychiatric patients: a study based on therapeutic drug monitoring
data. Ther Drug Monit 2015;37:589-593.
- Qin WJ, Zhang W, Liu ZQ, Chen XP, Tan ZR, Hu DL, et al . Rapid
clinical induction of bupropion hydroxylation by metamizole in healthy
Chinese men. Brit J Clin Pharmaco 2012;74:999–1004.
- Zhu AZ, Cox LS, Nollen N, Faseru B, Okuyemi KS, Ahluwalia JS, et
al . CYP2B6 and bupropion’s smoking-cessation pharmacology: the role
of hydroxybupropion. Clin Pharmacol Ther 2012;92:771-777.
- Ma H, Zhang WP, Yang XY, Zhang YX, Wei SJ, Zhang H, et al .
Effects of genetic polymorphisms of CYP2B6 on the pharmacokinetics of
bupropion and hydroxybupropion in healthy Chinese subjects. Med Sci
Monit 2018, 24:2158-2163.
- Mohamed EF, Mohamed MM, Trueman S, Feng T, Enejosa J, Fisniku O, et
al. Characterization of the effect of upadacitinib on the
pharmacokinetics of bupropion, a sensitive cytochrome p450 2b6 probe
substrate. Clinical Pharmacology in Drug Development 2020, Doi:
10.1002/cpdd.844.
- Faucette SR, Hawke RL, Lecluyse EL, Shord SS, Yan B, Laethem RM, et
al. Validation of bupropion hydroxylation as a selective marker of
human cytochrome P450 2B6 catalytic activity. Drug Metab Dispos
2000;28:1222-1230.
- Lainesse A, Hussain S, Monif T, Reyar S, Tippabhotla SK, Madan A,et al . Bioequivalence studies of tacrolimus capsule under
fasting and fed conditions in healthy male and female subjects.
Arzneimittel-Forsch 2008;58:242-247.
- Coles R, Kharasch ED. Stereoselective analysis of bupropion and
hydroxybupropion in human plasma and urine by LC/MS/MS. J Chromatogr B
2007;857:67-75.
- Tao WA, And FCG, Cooks RG. Mass Spectrometric Quantitation of Chiral
Drugs by the Kinetic Method. Anal Chem 2001;73:1692-1698.
- Parekh JM, Sutariya DK, Vaghela RN, Sanyal M, Yadav M, Shrivastav PS.
Sensitive, selective and rapid determination of bupropion and its
major active metabolite, hydroxybupropion, in human plasma by
LC-MS/MS: application to a bioequivalence study in healthy Indian
subjects. Biomed Chromatogr 2012;26:314-326.
- Denooz R, Mercerolle M, Lachâtre G, Charlier C. Ultra-performance
liquid chromatography- tandem mass spectrometry method for the
determination of bupropion and its main metabolites in human whole
blood. J Anal Toxicol 2010;34:280-286.
- Hiratsuka M, Hinai Y, Konno Y, Nozawa H, Konno S, Mizugaki M. Three
Novel Single Nucleotide Polymorphisms (SNPs) of the CYP2B6 Gene in
Japanese Individuals. Drug Metab Pharmacok 2011;26:544-7.
- Murphy J, Wang SS, Stieltjes H, Wajs E, Devineni D. Effect of food on
the pharmacokinetics of canagliflozin/metformin (150/1,000 mg)
immediate-release fixed-dose combination tablet in healthy
participants. Int J Clin Pharm Th 2015;53:256-264.
- Alkhalidi BA, Tamimi JJ, Salem II, Ibrahim H, Sallam AA. Assessment of
the bioequivalence of two formulations of clarithromycin
extended-release 500-mg tablets under fasting and fed conditions: a
single-dose, randomized, open-label, two-period, two-way crossover
study in healthy Jordanian male volunteers. Clin Ther
2008;30:1831-1843.
- Chen C, Bujanover S, Kareht S, Rapoport AM. Differential
pharmacokinetics of diclofenac potassium for oral solution vs.
immediate-release tablets from a randomized trial: effect of fed and
fasting conditions. J Head Face Pain 2015;55:265-275.
- Filipe A, Almeida S, Spínola ACF, Neves R, Trabelsi F, Torns A,et al . Bioequivalence study of two enteric-coated formulations
of pantoprazole in healthy volunteers under fed conditions.
Arzneimittel-Forsch 2008;58:451-456.
- Devineni D, Manitpisitkul P, Murphy J, Stieltjes H, Ariyawansa J,
Prospero NAD, et al . Effect of food on the pharmacokinetics of
canagliflozin, a sodium glucose co-transporter 2 inhibitor, and
assessment of dose proportionality in healthy participants. Clin Pharm
Drug Dev 2015;4:279–286.
- Ilic K, Hawke RL, Thirumaran RK, Schuetz EG, Hull JH, Kashuba AD,et al . The influence of sex, ethnicity, and CYP2B6 genotype on
bupropion metabolism as an index of hepatic CYP2B6 activity in humans.
Drug Metab Dispos 2013;41:575-581.